Indian startup news on 12 November 2026
It covers stake sale from BankBazaar, results from NPST, policy from Ola and funding for Olyv, QB MEN, Rigi and Rymo Technologies. Sectors: Financial Services, Mobility & Logistics, Healthcare & Life Sciences, Commerce & Consumer Brands and Consumer Internet & Media. Stages: Series C (extension), Pre-seed, Strategic and Early-stage. Based in Thane, Bengaluru, Hyderabad and Jaipur.
- BA
BankBazaar · Stake sale · 12 November 2026BankBazaar explores majority stake saleBankBazaar is an online financial services marketplace that also offers credit score tracking tools to Indian consumers - NP
NPST · Results · 12 November 2026NPST Q2 FY27 income jumps 50% to ₹73 croreNPST is a listed payments technology firm offering UPI solutions, merchant acquiring and regulatory tech products - OL
Ola · Policy · 12 November 2026 · ₹10 lakhConsumer regulator fines Ola ₹10 lakh over advance tippingOla runs a ride-hailing app in India, operated by ANI Technologies, where users book cabs, autos and bike taxis
- OL
Olyv · Funding · 12 November 2026 · ₹57.62 CrOlyv adds ₹58 crore to Series COlyv runs a Bengaluru-based online marketplace that links borrowers with lenders for small unsecured personal loans - PO
PopVax · Launch · 12 November 2026PopVax builds open personalised cancer vaccinePopVax is a Hyderabad biotech company that designs mRNA vaccines, with its own RNA Foundry for making them - QM
QB MEN · Funding · 12 November 2026QB MEN raises pre-seed round led by BeyondSeedQB MEN is a Jaipur menswear brand selling printed shirts, kurtas, co-ord sets and jackets that mix traditional Indian prints with modern cuts
- RI
Rigi · Funding · 12 November 2026 · ₹10 CrGoogle invests ₹10 crore in RigiRigi is a Bengaluru creator-economy startup that lets influencers run paid communities, subscriptions and digital products, and now also runs a short-video… - RT
Rymo Technologies · Funding · 12 November 20261Crowd backs rehab robotics startup RymoRymo builds robotics and AI tools that help clinicians run more consistent therapy for stroke, nerve and bone-injury patients